BIEGEL & WALLER LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 252 filers reported holding IMMUNOMEDICS INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
BIEGEL & WALLER LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2019$172,000
-4.4%
13,0000.0%0.10%
+4.3%
Q2 2019$180,000
-28.0%
13,0000.0%0.09%
-28.7%
Q1 2019$250,000
+34.4%
13,0000.0%0.13%
+17.3%
Q4 2018$186,000
-31.4%
13,0000.0%0.11%
-29.5%
Q3 2018$271,000
-12.0%
13,0000.0%0.16%
-18.8%
Q2 2018$308,000
+62.1%
13,0000.0%0.19%
+58.7%
Q1 2018$190,000
-9.5%
13,0000.0%0.12%
-0.8%
Q4 2017$210,000
+15.4%
13,0000.0%0.12%
+7.0%
Q3 2017$182,000
+58.3%
13,0000.0%0.11%
+62.9%
Q2 2017$115,000
+36.9%
13,0000.0%0.07%
+20.7%
Q1 2017$84,000
+50.0%
13,0000.0%0.06%
+48.7%
Q4 2016$56,00013,0000.04%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders